BR0210410A - Processo para produção do derivado de piperidina, fexofenadina - Google Patents
Processo para produção do derivado de piperidina, fexofenadinaInfo
- Publication number
- BR0210410A BR0210410A BR0210410-5A BR0210410A BR0210410A BR 0210410 A BR0210410 A BR 0210410A BR 0210410 A BR0210410 A BR 0210410A BR 0210410 A BR0210410 A BR 0210410A
- Authority
- BR
- Brazil
- Prior art keywords
- production
- fexofenadine
- piperidine derivative
- processes
- relates
- Prior art date
Links
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 title abstract 3
- 229960003592 fexofenadine Drugs 0.000 title abstract 2
- 150000003053 piperidines Chemical class 0.000 title abstract 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 abstract 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 229940008201 allegra Drugs 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000932 sedative agent Substances 0.000 abstract 1
- 230000001624 sedative effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/738—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29839701P | 2001-06-15 | 2001-06-15 | |
| PCT/EP2002/006424 WO2002102776A1 (en) | 2001-06-15 | 2002-06-12 | Process for the production of the piperidine derivative fexofenadine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0210410A true BR0210410A (pt) | 2004-08-17 |
Family
ID=23150325
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0210410-5A BR0210410A (pt) | 2001-06-15 | 2002-06-12 | Processo para produção do derivado de piperidina, fexofenadina |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6743941B2 (enExample) |
| EP (1) | EP1401816B1 (enExample) |
| JP (1) | JP4344230B2 (enExample) |
| KR (1) | KR100903285B1 (enExample) |
| CN (1) | CN1229347C (enExample) |
| AR (1) | AR037005A1 (enExample) |
| AT (1) | ATE386021T1 (enExample) |
| AU (1) | AU2002320847B2 (enExample) |
| BR (1) | BR0210410A (enExample) |
| CA (1) | CA2450313C (enExample) |
| DE (1) | DE60225008T2 (enExample) |
| DK (1) | DK1401816T3 (enExample) |
| ES (1) | ES2298384T3 (enExample) |
| HU (1) | HUP0401125A2 (enExample) |
| IL (2) | IL159304A0 (enExample) |
| MX (1) | MXPA03010960A (enExample) |
| NO (1) | NO20035572L (enExample) |
| NZ (1) | NZ530153A (enExample) |
| PL (1) | PL364369A1 (enExample) |
| PT (1) | PT1401816E (enExample) |
| WO (1) | WO2002102776A1 (enExample) |
| ZA (1) | ZA200308697B (enExample) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7498443B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of carebastine |
| US7498345B2 (en) * | 2004-09-17 | 2009-03-03 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
| CN100453522C (zh) * | 2005-01-26 | 2009-01-21 | 中国科学技术大学 | 4-[4-(1-乙氧基酰基-1-甲基乙基苯)]-4-氧代丁酸的制备方法 |
| WO2007135693A2 (en) * | 2006-05-18 | 2007-11-29 | Ind-Swift Laboratories Limited | Intermediates useful for the preparation of antihistaminic piperidine derivative |
| ITMI20061491A1 (it) * | 2006-07-27 | 2008-01-28 | Archimica Srl | Processo per la preparazione di fexofenadina. |
| ITMI20061492A1 (it) * | 2006-07-27 | 2008-01-28 | Archimica Srl | Processo per la preparazione di fexofenadina. |
| CN102070490B (zh) * | 2009-11-21 | 2014-07-30 | 浙江华海药业股份有限公司 | 一种非索非那定中间体2-(4-(4-羟基丁酰基)苯基)-2-甲基丙氰的制备方法 |
| CN102070570A (zh) * | 2009-11-21 | 2011-05-25 | 浙江华海药业股份有限公司 | 一种非索非那定中间体2-甲基-2(4-(2-氧代四氢呋喃-3-羰基)苯基)丙氰及其盐的制备方法 |
| CN107922387B (zh) | 2015-06-15 | 2024-11-22 | 阿沙纳生物科学公司 | Erk1与erk2的杂环抑制剂及其在癌症治疗中的应用 |
| CN104876853B (zh) * | 2015-06-17 | 2017-06-16 | 苏州卫生职业技术学院 | 盐酸非索非那定的合成方法 |
| RS59874B1 (sr) | 2015-10-22 | 2020-03-31 | Sanofi Aventis Deutschland | Proces za pripremu feksofenadina i njegovih intermedijara |
| WO2018183762A1 (en) | 2017-03-29 | 2018-10-04 | United States Government As Represented By The Department Of Veterans Affairs | Methods and compositions for treating cancer |
| US20230027072A1 (en) | 2019-10-28 | 2023-01-26 | Asana Biosciences, Llc | Improved methods, kits, compositions and dosing regimens for the use of heterocyclic inhibitors of erk1 and erk2 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2946809A1 (de) * | 1979-11-20 | 1981-06-11 | A. Nattermann & Cie GmbH, 5000 Köln | 4-phenyl-4-oxo-buttersaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende arzneimittel |
| IT1200123B (it) | 1985-09-27 | 1989-01-05 | Ind Chimica Srl | Procedimento per la preparazione di alfa-(p-terbutilfenil)-4-(idrossidifenilmetil)-1-piperidinobutanolo |
| EP0347123A3 (en) | 1988-06-17 | 1991-07-03 | Fisons Corporation | Dibenzo-cycloheptenyl, -cycloheptyl and -oxepinyl amines having antihistaminic properties |
| IT1249684B (it) | 1991-07-19 | 1995-03-09 | Sorin Biomedica Spa | Epitopi della proteina env del virus dell'epatite c. |
| JP3686950B2 (ja) * | 1992-04-10 | 2005-08-24 | メレル ファーマスーティカルズ インコーポレイテッド | ピペリジン誘導体類の新規な方法 |
| DK1026147T3 (da) | 1993-06-24 | 2004-03-22 | Albany Molecular Res Inc | Forbindelser, der er anvendelige som mellemprodukter i fremstillingen af piperidinderivater |
-
2002
- 2002-06-11 US US10/166,893 patent/US6743941B2/en not_active Expired - Lifetime
- 2002-06-12 WO PCT/EP2002/006424 patent/WO2002102776A1/en not_active Ceased
- 2002-06-12 AT AT02754657T patent/ATE386021T1/de active
- 2002-06-12 HU HU0401125A patent/HUP0401125A2/hu unknown
- 2002-06-12 CA CA2450313A patent/CA2450313C/en not_active Expired - Fee Related
- 2002-06-12 PT PT02754657T patent/PT1401816E/pt unknown
- 2002-06-12 EP EP02754657A patent/EP1401816B1/en not_active Expired - Lifetime
- 2002-06-12 IL IL15930402A patent/IL159304A0/xx unknown
- 2002-06-12 JP JP2003505319A patent/JP4344230B2/ja not_active Expired - Fee Related
- 2002-06-12 PL PL02364369A patent/PL364369A1/xx not_active Application Discontinuation
- 2002-06-12 DK DK02754657T patent/DK1401816T3/da active
- 2002-06-12 ES ES02754657T patent/ES2298384T3/es not_active Expired - Lifetime
- 2002-06-12 CN CNB028119312A patent/CN1229347C/zh not_active Expired - Fee Related
- 2002-06-12 AU AU2002320847A patent/AU2002320847B2/en not_active Ceased
- 2002-06-12 NZ NZ530153A patent/NZ530153A/en not_active IP Right Cessation
- 2002-06-12 BR BR0210410-5A patent/BR0210410A/pt not_active IP Right Cessation
- 2002-06-12 KR KR1020037016429A patent/KR100903285B1/ko not_active Expired - Fee Related
- 2002-06-12 MX MXPA03010960A patent/MXPA03010960A/es active IP Right Grant
- 2002-06-12 DE DE60225008T patent/DE60225008T2/de not_active Expired - Lifetime
- 2002-06-14 AR ARP020102261A patent/AR037005A1/es unknown
-
2003
- 2003-11-07 ZA ZA200308697A patent/ZA200308697B/en unknown
- 2003-12-10 IL IL159304A patent/IL159304A/en not_active IP Right Cessation
- 2003-12-12 NO NO20035572A patent/NO20035572L/no unknown
-
2004
- 2004-04-22 US US10/829,803 patent/US7235665B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA2450313A1 (en) | 2002-12-27 |
| CN1516689A (zh) | 2004-07-28 |
| US7235665B2 (en) | 2007-06-26 |
| MXPA03010960A (es) | 2004-02-27 |
| US20030105329A1 (en) | 2003-06-05 |
| IL159304A (en) | 2010-02-17 |
| PL364369A1 (en) | 2004-12-13 |
| DE60225008D1 (de) | 2008-03-27 |
| EP1401816B1 (en) | 2008-02-13 |
| WO2002102776A1 (en) | 2002-12-27 |
| DK1401816T3 (da) | 2008-06-09 |
| CA2450313C (en) | 2010-08-10 |
| ES2298384T3 (es) | 2008-05-16 |
| AR037005A1 (es) | 2004-10-20 |
| JP4344230B2 (ja) | 2009-10-14 |
| KR100903285B1 (ko) | 2009-06-17 |
| JP2005502603A (ja) | 2005-01-27 |
| ATE386021T1 (de) | 2008-03-15 |
| HK1063795A1 (en) | 2005-01-14 |
| IL159304A0 (en) | 2004-06-01 |
| US6743941B2 (en) | 2004-06-01 |
| KR20040010720A (ko) | 2004-01-31 |
| NO20035572L (no) | 2004-02-16 |
| ZA200308697B (en) | 2004-09-03 |
| NZ530153A (en) | 2005-07-29 |
| US20040198983A1 (en) | 2004-10-07 |
| EP1401816A1 (en) | 2004-03-31 |
| HUP0401125A2 (hu) | 2004-09-28 |
| PT1401816E (pt) | 2008-04-08 |
| DE60225008T2 (de) | 2009-01-29 |
| CN1229347C (zh) | 2005-11-30 |
| AU2002320847B2 (en) | 2007-09-20 |
| NO20035572D0 (no) | 2003-12-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PY0227623A (es) | Sales de acido succinico de 5,7,14-triazatetraciclo [10.3.1.02,11.04,9] - hexadeca-2(11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas | |
| BR0017030A (pt) | Derivados de tiazolilamida | |
| BR0316375A (pt) | Diazinopirimidinas | |
| BR0209580A (pt) | Derivados de ciclohexan-1, 4 diamina substituìdos | |
| DK1613304T3 (da) | DPP-IV-inhibitorer | |
| BR0017043A (pt) | Imidazo[1,3,5]triazinonas e sua aplicação | |
| BR0208741A (pt) | Derivados de piperidina | |
| AR022469A1 (es) | Uso de acidos isoxazolcarboxilicos sustituidos y derivados y nuevas sustancias | |
| PT1259498E (pt) | Derivados do 8,8a-di-hidroindeno[1,2-d]tiazole substituidos na posicao 8a, processo para a sua preparacao e sua utilizacao como medicamentos, p. ex. como anorecticos | |
| BRPI0108990B8 (pt) | processo para preparação de derivados de pirimidona com atividade antifungos | |
| BR0007643A (pt) | Processo para obter ésteres de (nitroximetil) fenila de derivados de aspirina, e, (hidroximetil) feniléter de derivados de aspirina | |
| PT1265888E (pt) | Processo para producao de derivados de (s)-nicotina 6-substituida e compost0s intermediarios | |
| BR9808770A (pt) | Conjugado medicamentoso, método para suaprodução e seu uso | |
| BR0311347A (pt) | Alcanóis bis-aromáticos | |
| MXPA03010960A (es) | Proceso para la produccion de fexofenadina derivado de piperidina. | |
| BR0114437A (pt) | Derivados de acido propiÈnico | |
| BR0011996A (pt) | Preparação de piperidin-4-onas substituìdas | |
| BR0013313A (pt) | Derivados substituìdos de pirrolidino-2,3,4- triona-3-oxina eficazes como antagonistas de receptores de nmda | |
| ATE389405T1 (de) | Fexofenadine hydrochlorid polymorph | |
| BR9805437A (pt) | Derivados de benzocicloalquenos heterocìclicos, processo para fabricação de derivados de benzocicloalquenos heterocìclicos e uso de derivados de benzocicloalquenos heterocìclicos. | |
| BRPI0411652A (pt) | processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos | |
| UY27001A1 (es) | Derivados de la indolilpiperidina como agentes antihistamínicos y antialérgicos | |
| MXPA04006125A (es) | Utilizacion de desoxipeganina en el tratamiento de la depresion clinica. | |
| PT1246790E (pt) | Bases de mannich de 1- e 2-naftol substituido | |
| EA200300771A1 (ru) | Новая соль бензоилгуанидина |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INTE.CL: C07D 211/22, C07C 69/730 Ipc: C07D 211/22 (2011.01), C07C 69/738 (2011.01), A61P |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE 8A E 9A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |